Background The world is now challenging the pandemic of COVID-19 infection. This is the third and most extensive pandemic. Previous studies showed the plausibility of vitamin D prophylaxis and therapy for COVID-19, particularly in settings where hypovitaminosis D is frequent. Recent study from Indonesian showed that the prevalence of vitamin D deficiency was 23.0%. The examination of vitamin D status is not a routine in the Indonesian clinical setting. Methods This study is a case series from confirmed cases of COVID-19 in Bethesda Hospital Yogyakarta Indonesia. The data of clinical symptoms, signs and laboratory examinations were obtained from the electronic medical records. The vitamin D status was measured by Enzyme-Linked Fluorescent Assay (ELFA) method. We searched PubMed and Google Scholar for studies that included terms for Vitamin D and COVID-19. Results The data were obtained from 10 participants consisting of 50% male and 50% female. The mean age was 49.6 years. The prevalence of vitamin D deficiency in this study was 90% (vitamin D levels < 20 ng/mL) and 10% of insufficiency (vitamin D levels < 30 ng/mL). Patients in this study had various symptoms such as fatigue (60%), fever (50%), dry cough (40%), non-specific headache (10%), and diarrhea (10%); have no symptoms (20%); and also had the various chronic diseases as comorbidity such as hypertension (40%), diabetes (10%), COPD (10%), and post stroke (10%). Conclusions All of the COVID-19 patients in this study had hypovitaminosis D. The prevalence of vitamin D deficiency in this case series is 90% and only 1 patient (10%) had vitamin D insufficiency. There are many health benefits of vitamin D and very few adverse effects. Randomized controlled trials need to determine and evaluate this recommendation in preventing or treating COVID-19. Clinicians should continue to treat people with vitamin D deficiency especially in managing COVID-19 patients.

Coronavirus Disease 2019 (COVID‐19) is a public health emergency of international concern with increasing cases globally, including in Indonesia. COVID‐19 clinical manifestations ranging from asymptomatic, acute respiratory illness, respiratory failure that necessitate mechanical ventilation and support in an intensive care unit (ICU), to multiple organ dysfunction syndromes. Some patients might present with happy hypoxia, a condition where patients have low oxygen saturations (S pO2 < 90%), but are not in significant respiratory distress and often appear clinically well, which is confusing for the doctors and treatment strategies. Most infections are mild in nature and have a relatively low case fatality rate (CFR); however, critical COVID‐19 patients who need support in ICU have high CFR. We would like to report a case of happy hypoxia in a critical COVID‐19‐positive ICU hospitalized patient who survived from Indonesia.

No abstract

Background The world is now challenging the pandemic of COVID-19 infection. Previous studies showed the plausibility of Vitamin D prophylaxis and therapy for COVID-19, particularly in settings where hypovitaminosis D is frequent. Recent study from Indonesian showed that prevalence of vitamin D deficiency were 23.0%. The examination of Vitamin D status is not a routine in Indonesian clinical setting. Methods This study is a Case Series from confirmed cases of COVID-19 in Bethesda hospital Yogyakarta Indonesia. The data of clinical symptoms, clinical signs, and laboratory examination were obtained from electronic medical record. The vitamin D status was measured by standardized laboratory method. We searched PubMed and Google Scholar for studies that included terms for Vitamin D and COVID-19. Results The data was obtained from 10 participants consist of 50% male and 50% female. The mean of age was 49.6 years. The prevalence of vitamin D deficiency in this case was 90% and 10% of insufficiency. Patients in this case had various symptom and also had various chronic disease as comorbidity. Conclusions The prevalence of vitamin D deficiency in this case series in Bethesda hospital Yogyakarta, Indonesia is 90% and 10% vitamin D insufficiency. We found no clinical evidence that vitamin D supplements are beneficial in preventing or treating COVID-19. Randomized controlled trials need to determine and evaluated this recommendation.

Indonesia has fertile soil, natural resources and abundant marine resources. However, Indonesia is also not immune to the risk of natural disasters which are a series of events that disturb and threaten life safety and cause material and non-material losses. Indonesia's strategic geological location causes Indonesia to be frequently hit by earthquakes, volcanic eruptions and other natural disasters. From the data collected, natural disasters that occurred in Indonesia consisted of several categories, namely earthquakes, volcanic eruptions, floods, landslides, tornados, and tsunamis. Many natural disasters in Indonesia have caused casualties, both fatalities and injuries, destroying the surrounding area and destroying infrastructure and causing property losses. The trend of increasing incidence of natural disasters needs to be further investigated to prevent the number of victims from increasing. This information can be obtained through a data mining approach given the large amount of data available. In relation to natural disaster data, clustering techniques in data mining are very useful for grouping natural disaster data based on the same characteristics so that the data can be adopted as a groundwork for predicting natural disaster events in the future. Thus, this research is supposed to group natural disaster data using clustering techniques using the k-means algorithm into several groups, in terms of natural disaster types, time of disaster, number of victims, and damage to various facilities as a result of natural disasters

No abstract

No abstract

We have read with great interest the articles regarding cutaneous manifestations in Coronavirus Disease 2019 (COVID-19) infection. Studies showed 20.4% of COVID-19 patients developed cutaneous manifestations. COVID-19 causes vascular endothelial injury, vasculitis and prothrombotic state which might be the underlying cause of hemorrhagic cutaneous manifestations, disseminated intravascular coagulation (DIC), and multiple organ failures. To date, hemorrhagic cutaneous manifestations reported are chilblain-like lesion, purpura to ecchymosis, livedo reticularis, and dry gangrene. We present a case of ecchymosis in COVID-19-positive ICU hospitalized patient.